ILSE Intralase Corp (MM)

IRVINE, Calif., Oct. 2 /PRNewswire-FirstCall/ -- IntraLase(R) Corp. (NASDAQ:ILSE) announced today that it will report its 2006 third quarter results on Wednesday, October 25, 2006. A news release will be issued and will also be posted on the company's website at http://www.intralase.com/. Also on October 25, IntraLase will hold an investor conference call at 11:00 a.m. Eastern Time to discuss the company's results. Hosting the call will be Robert J. Palmisano, President and Chief Executive Officer, and Shelley B. Thunen, Executive Vice President and Chief Financial Officer. The conference call will be webcast live and can be accessed on the IntraLase website. The webcast is available to both institutional and individual investors. Individual investors can access the webcast at: http://www.fulldisclosure.com/. Institutional investors can access the webcast via a password-protected event management site at http://www.streetevents.com/. The live call may also be accessed by telephone at (800) 510-0219 or for international parties at (617) 614-3451 and entering the confirmation code 40878316 between 10:50 a.m. and 11:00 a.m. Eastern Time. The webcast will be archived and available for replay until 8:00 p.m. Eastern Time on November 1, 2006. A telephone rebroadcast of the call may be accessed October 25, 2006 beginning at 1:00 p.m. Eastern Time for a one-week period by calling (888) 286-8010 or for international parties (617) 801-6888 and entering confirmation code 16958375. About IntraLase Corp. IntraLase designs, develops, and manufactures an ultra-fast laser that is revolutionizing refractive and corneal surgery by creating safe and more precise corneal incisions. Delivering on the promise of ophthalmic laser technology, the IntraLase FS laser, related software, and disposable devices replace the hand-held microkeratome blade used during LASIK surgery. The unsurpassed accuracy of IntraLase's computer-controlled femtosecond laser has been shown to improve safety profiles and visual outcomes when used during LASIK. Additionally, the IntraLase FS laser creates precision-designed intracorneal incisions that when combined can be used during lamellar and penetrating keratoplasty, and intrastromal ring implantation. IntraLase is presently in the process of commercializing applications of its technology in the treatment of corneal diseases that require corneal transplant surgery. The company's proprietary laser and disposable patient interfaces are presently marketed throughout the United States and 31 other countries. IntraLase is headquartered and manufactures its products in Irvine, California. For additional information, visit the company's web site: http://www.intralase.com/. DATASOURCE: IntraLase Corp. CONTACT: Krista Mallory, Director, Investor Relations and Corporate Communications of IntraLase Corp., +1-949-859-5230, ext. 260, Web site: http://www.intralase.com/

Copyright